Glycomics is a branch of biotechnology that focuses on the study of carbohydrates, or glycans, and their roles in biological processes. Glycans are complex molecules that are found in all living organisms and are involved in a variety of biological functions, including cell-cell recognition, cell adhesion, and immune system regulation. Glycomics research has been used to develop new treatments for diseases such as cancer, diabetes, and Alzheimer's. The glycomics market is driven by the increasing demand for new treatments for various diseases, as well as the growing need for personalized medicine. The market is expected to grow at a steady rate due to the increasing number of research and development activities in the field. Some of the major companies in the glycomics market include GlycoMimetics, Inc., GlycoBioTech, Inc., GlycoVaxyn AG, GlycoMark, Inc., and GlycoThera, Inc. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
